Chronic kidney disease found to be 58% more likely to develop in individuals with than without the sleep disorder.
New findings suggest the medication induces beneficial renal structural changes.
In a phase 2 trial, roxadustat maintained hemoglobin levels over 19 weeks as well as epoetin alfa.
Antibiotics selected based on results of pre-biopsy rectal swab cultures.
Combination angiogenesis inhibition can be safely administered with supportive measures in metastatic castration-resistant prostate cancer (mCRPC).